Thrombotic Microangiopathy With Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma

Case Reports in Oncology - Switzerland
doi 10.1159/000494080
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

S. Karger AG

Related search

Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pulmonary Thrombotic Microangiopathy Caused by Gastric Carcinoma

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2010English

Ixazomib-Induced Thrombotic Microangiopathy

American Journal of Hematology
Hematology
2017English

Radioactive Iodine Ablation May Not Decrease the Risk of Recurrence in Intermediate-Risk Papillary Thyroid Carcinoma

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Pulmonary Tumor Thrombotic Microangiopathy Caused by Prostate Carcinoma

Acta Radiologica Open
2016English

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research
Cancer ResearchOncology
2014English

Radiation Exposure From Outpatient Radioactive Iodine (131I) Therapy for Thyroid Carcinoma

JAMA - Journal of the American Medical Association
Medicine
2000English

Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy